TANG CAPITAL MANAGEMENT LLC Diversified Active

Location: San Diego, CA

CIK: 0001232621 · Show all filings

Period: Q2 2013 (Next →)

Filing Date: Aug 14, 2013

Total Value: $254M (30.9% shares, 69.1% debt)

Holdings (21)

— PDL BIOPHARMA INC 17.2%
Value $43.58M Shares 30,974,000 Share Price $1.41 Est. Cost/Share $1.41 Unrealized @ Report Date —
— MANNKIND CORP 13.3%
Value $33.63M Shares 34,144,000 Share Price $0.99 Est. Cost/Share $0.99 Unrealized @ Report Date —
— OPKO HEALTH INC 12.1%
Value $30.8M Shares 29,500,000 Share Price $1.04 Est. Cost/Share $1.04 Unrealized @ Report Date —
— PACIRA PHARMACEUTICALS INC 10.1%
Value $25.76M Shares 18,500,000 Share Price $1.39 Est. Cost/Share $1.39 Unrealized @ Report Date —
— SALIX PHARMACEUTICALS INC 7.8%
Value $19.84M Shares 300,000 Share Price $66.15 Est. Cost/Share $66.15 Unrealized @ Report Date —
— DENDREON CORP 7.5%
Value $19.09M Shares 26,515,000 Share Price $0.72 Est. Cost/Share $0.72 Unrealized @ Report Date —
— INTERMUNE INC 5.5%
Value $14.07M Shares 17,000,000 Share Price $0.83 Est. Cost/Share $0.83 Unrealized @ Report Date —
— NEKTAR THERAPEUTICS 4.1%
Value $10.52M Shares 911,053 Share Price $11.55 Est. Cost/Share $11.55 Unrealized @ Report Date —
— DEPOMED INC 4.1%
Value $10.35M Shares 1,842,280 Share Price $5.62 Est. Cost/Share $5.62 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 4.0%
Value $10.16M Shares 182,300 Share Price $55.74 * Est. Cost/Share $62.32 Unrealized @ Report Date 0.0%
— ONCOGENEX PHARMACEUTICALS INC 3.6%
Value $9.144M Shares 933,100 Share Price $9.80 Est. Cost/Share $9.80 Unrealized @ Report Date —
— MANNKIND CORP 3.0%
Value $7.707M Shares 1,184,784 Share Price $6.50 Est. Cost/Share $6.50 Unrealized @ Report Date —
— ENDOCYTE INC 2.4%
Value $6.115M Shares 465,763 Share Price $13.13 Est. Cost/Share $13.13 Unrealized @ Report Date —
— SAVIENT PHARMACEUTICALS INC 1.8%
Value $4.571M Shares 30,476,000 Share Price $0.15 Est. Cost/Share $0.15 Unrealized @ Report Date —
— CORSICANTO LTD 1.1%
Value $2.722M Shares 2,500,000 Share Price $1.09 Est. Cost/Share $1.09 Unrealized @ Report Date —
— NAVIDEA BIOPHARMACEUTICALS INC 0.9%
Value $2.318M Shares 868,079 Share Price $2.67 Est. Cost/Share $2.67 Unrealized @ Report Date —
— ROCKWELL MEDICAL INC 0.6%
Value $1.618M Shares 448,146 Share Price $3.61 Est. Cost/Share $3.61 Unrealized @ Report Date —
— SUPERNUS PHARMACEUTICALS INC 0.5%
Value $1.253M Shares 10,000,000 Share Price $0.13 Est. Cost/Share $0.13 Unrealized @ Report Date —
— DENDREON CORP 0.1%
Value $328K Shares 79,600 Share Price $4.12 Est. Cost/Share $4.12 Unrealized @ Report Date —
— CYCLACEL PHARMACEUTICALS INC 0.1%
Value $218K Shares 73,895 Share Price $2.95 Est. Cost/Share $2.95 Unrealized @ Report Date —
— AMBIT BIOSCIENCES CORP 0.0%
Value $0 Shares 46 Share Price $0.00 Est. Cost/Share — Unrealized @ Report Date —